We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

172 hedge funds and large institutions have $2.46B invested in Medicines Co in 2013 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more call options, than puts

Call options by funds: $16.8M | Put options by funds: $3.66M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

72% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 47

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

21% more capital invested

Capital invested by funds: $2.04B → $2.46B (+$421M)

2% more funds holding

Funds holding: 168 → 172 (+4)

Holders
172
Holders Change
+4
Holders Change %
+2.38%
% of All Funds
5.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
31
Increased
81
Reduced
47
Closed
25
Calls
$16.8M
Puts
$3.66M
Net Calls
+$13.1M
Net Calls Change
+$4.91M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$92.5M
2
PHS
PFM Health Sciences
California
+$75.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.6M
4
FCM
Frontier Capital Management
Massachusetts
+$27M
5
BFA
BlackRock Fund Advisors
California
+$26.9M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$51.5M
2
BM
Bridger Management
New York
-$43.4M
3
RIM
RS Investment Management
California
-$27.3M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$19.7M
5
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$15.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$18.8M +$1.92M +60,303 +12%
CCI
27
Columbus Circle Investors
$16.9M -$8.79M -276,089 -35%
TA
28
Teachers Advisors
New York
$15.5M +$328K +10,282 +2%
WC
29
Wexford Capital
Florida
$15.3M +$2.8M +88,020 +24%
O
30
OppenheimerFunds
New York
$14.7M -$4.74M -148,720 -25%
Norges Bank
31
Norges Bank
Norway
$13.2M +$5.18M +162,502 +70%
Citadel Advisors
32
Citadel Advisors
Florida
$12.1M +$9.27M +291,118 +418%
Public Employees Retirement Association of Colorado
33
Public Employees Retirement Association of Colorado
Colorado
$11.9M – – –
CCM
34
Cadence Capital Management
Massachusetts
$11.2M +$1.16M +36,364 +12%
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$11.1M +$10.6M +331,600 New
SGA
36
Sector Gamma AS
Norway
$10.7M +$1.39M +43,600 +16%
TCIM
37
TIAA CREF Investment Management
New York
$10.7M +$433K +13,581 +4%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$10.6M +$8.66M +271,744 +619%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$10.5M +$9.15M +287,333 +1,155%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$10.3M +$2.49M +78,183 +34%
Deutsche Bank
41
Deutsche Bank
Germany
$9.87M +$401K +12,600 +4%
Goldman Sachs
42
Goldman Sachs
New York
$9.57M +$4.09M +128,268 +82%
JGC
43
J. Goldman & Co
New York
$8.84M +$8.4M +263,750 New
SFM
44
Soros Fund Management
New York
$8.38M +$3.19M +100,000 +67%
Ameriprise
45
Ameriprise
Minnesota
$8.05M +$993K +31,178 +15%
TC
46
TFS Capital
Pennsylvania
$7.63M +$7.25M +227,496 New
Allianz Asset Management
47
Allianz Asset Management
Germany
$7.54M +$1M +31,440 +16%
Arrowstreet Capital
48
Arrowstreet Capital
Massachusetts
$7.46M +$2.03M +63,884 +40%
PAM
49
Panagora Asset Management
Massachusetts
$7.4M -$2.47M -77,523 -26%
QBFM
50
QS Batterymarch Financial Management
New York
$7.37M – – –
1
2
3 4 5

MDCO Hedge Fund Activity: Q3 2013 in Review

172 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q3 2013, worth a combined $2.46B — up 21% from $2.04B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MDCO positions and 25 closed out — a net gain of 6 holders — while 81 added to existing stakes and 47 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $92.5M. The largest seller was HealthCor Management, exiting entirely with an estimated $51.5M sold.

  • 172 institutional investors held Medicines Co (MDCO) as of Q3 2013, up from 168 in Q2 2013.
  • Funds reported $2.46B of Medicines Co stock for Q3 2013, up 21% quarter-over-quarter.
  • 31 funds opened new Medicines Co positions in Q3 2013 and 25 closed out, a net change of +6 holders.
  • The largest Medicines Co buyer in Q3 2013 was Wellington Management Group, an estimated $92.5M added.
  • The largest Medicines Co seller in Q3 2013 was HealthCor Management, an estimated $51.5M sold.

Based on aggregated 13F filings for Q3 2013.